MedPath

Cohort study of Chinese and Western medicine against severe influenza

Not Applicable
Recruiting
Conditions
influenza
Registration Number
ITMCTR2100004555
Lead Sponsor
Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

According to the influenza diagnosis and treatment plan (2018 Edition) issued by the national health and Family Planning Commission, the patient was diagnosed with influenza, and the condition met one of the following conditions:
1. Continuous high fever (39 degrees C) > 3 days, accompanied by severe cough, purulent sputum, blood sputum, or chest pain;
2. Respiratory tachycardia >= 24 times / min, dyspnea and cyanosis of lips;
3. Change of mind: slow reaction, drowsiness, restlessness, convulsion, etc;
4. Severe vomiting, diarrhea and dehydration;
5. It is complicated with pneumonia;
6. The original underlying diseases were significantly aggravated.

Exclusion Criteria

The continuous cases of severe influenza treated with Xiyanping injection and Western medicine alone were treated in each research center during the study period.

Study & Design

Study Type
Observational study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ength of hospitalization;
Secondary Outcome Measures
NameTimeMethod
Incidence of complications;Antipyretic time;28 day mortality;Antibiotic use rate and bacterial infection rate;
© Copyright 2025. All Rights Reserved by MedPath